Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Ethosuximide manufacturers

Filters

3 products found

ethosuximide

Syrup 50 mg/ml - 250 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria , Bulgaria , Czech Republic , Estonia , France , Germany , Hungary , Italy , Latvia , Lithuania , Mexico , Poland , Romania , Slovakia , Sweden , United Kingdom
Comments
Indication: Epilepsy
Manufacturer #8070
A pharmaceutical manufacturer that develops, produces and markets both branded medicines and generics, with a focus on treatments for serious and chronic diseases. The company emphasises partnerships, licensing opportunities and specialist indication areas, supporting the global supply of pharmaceutical products via its research & development and manufacturing capabilities.

Manufacturer usually replies in 28 days

ethosuximide

Oral solution 50 mg/ml

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Italy , Latvia , Liechtenstein , Lithuania , Luxembourg , Malta , Netherlands , Norway , Poland , Portugal , Spain , Sweden , United Kingdom , Vietnam
Available for
Licensing with supply, Distribution only
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 29 days

ethosuximide

Oral solution 250 mg/5 ml, 500 mg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #38597

The manufacturer is a global CDMO and GMP manufacturer operating since 2020. It functions as a CTD dossier owner and manufacturer, offering full drug-product services and acting as a CTD dossier owner and manufacturer. With approximately 500–1,000 employees worldwide, it maintains manufacturing sites in Europe, Japan, and North America and sells products across those regions. As a GMP manufacturer, it holds GMP approvals for sterile and non-sterile production. Its production lines cover sterile liquids (IV bags, ampoules, vials using BFS), non-sterile liquids, semi-solids (creams, ointments, gels), oral solids, suppositories, and more. The site in Leipzig features multiple semi-solid lines plus three non-sterile liquid production lines; recently, a new liquid filling and cartoning line was added, boosting capacity significantly. As CTD dossier owner and manufacturer, it manages regulatory dossiers and production, and as CTD dossier owner and manufacturer, it ensures compliance across development and manufacturing.

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Ethosuximide

Ethosuximide is a medication used to treat absence seizures. It can be used as a standalone therapy or with other antiseizure medications like valproic acid. Ethosuximide is taken by mouth. It is approved for absence seizures. Ethosuximide is a drug of choice for treating absence seizures as it lacks the idiosyncratic hepatotoxicity of the valproic acid. Ethosuximide sold under the brand name Zarontin among others. Bayer Ag filed for the first patents and got them approved for medical use in the United States in 1960. Ethosuximide is listed on WHO's List of Essential Medicines and sold as a generic medication.

Dosage Forms & Strengths

Ethosuximide is available as a capsule in 250 mg strength and as a syrup in 250mg/5mL. In the treatment of Absence Seizures, the usual recommended dose is 500 a day which can be increased by 250 mg a day but generally not exceeding 1.5 g a day in total dose. In the Therapeutic range, the dose is between 40-100 mg/L and will need between 4-7 days to reach steady-state

The Price of Ethosuximide

In the USA, the consumers pay an average retail price of $256.30 for the supply of 120 capsules of a generic brand. However, the price of this medicine is significantly cheaper in the developing world, for example, the generic version of a bottle containing 50mg of this costs around USD 0.22.

How does Ethosuximide work?

Ethosuximide’s exact mechanism of action is not yet been entirely understood fully. However, it has been postulated that Ethosuximide work through a partial antagonism of T-type calcium channels of the thalamic neurons. The result of this antagonism is a decrease in burst firing of Thalamocortical neurons, all this cascading effect stabilizes the nerve activity in the brain resulting in the prevention of seizures.

Finding Ethosuximide Manufacturers and Suppliers

The best way to find and gain access to Ethosuximide manufacturers and Ethosuximide suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Ethosuximide can be a the time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Ethosuximide to work with. You can fine-tune your search results using various filters too, letting you search for Ethosuximide from specific countries.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.